Amrutanjan Healt Q2 FY27 Results (NSE: AMRUTANJAN)

· Analysis by Alpha Inflection

Signal: Margin expansion

The read

The key inflection is the operating-margin recovery to 17.5% from the reported 9.8% in Q1FY27, supported by gross-margin expansion to 55.1% and faster Women's Hygiene & Personal Care growth of 23.5% YoY. However, H1 operating cash flow fell to ₹215.95 lakh from ₹1,090.72 lakh as inventory increased ₹2,073.56 lakh and the business invested ₹3,648.39 lakh in capex.

Amrutanjan Healt Q2 FY27 key financials
MetricValueYoYQoQ
Revenue₹135.18 Cr+14.8%+31.3%
EBIT₹20.12 Cr+34.4%
Net profit₹17.28 Cr+23.8%
EPS₹5.98+23.8%
EBIT margin14.9%

P&L walk

Revenue increased 14.8% YoY and 31.3% QoQ to ₹13,517.89 lakh, while gross margin expanded 406bps YoY to 55.1% and operating margin recovered to 17.5% from the 9.8% reported in Q1FY27; PAT grew 23.8% to ₹1,727.99 lakh, with no current-quarter exceptional charge.

Segments

OTC Products remains the earnings engine with ₹9,093.76 lakh revenue and ₹2,328.91 lakh result, while Women's Hygiene & Personal Care grew 23.5% YoY to ₹4,048.22 lakh and turned profitable at ₹46.19 lakh; Beverages dragged with a ₹241.24 lakh loss.

Key positives

Key concerns

View original filing

Research and educational content only. Not investment advice.